EP2802351
Miðlar til að meðhöndla þríneikvætt brjóstakrabbamein
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
9.1.2013EP published:
27.3.2019EP application number:
13735811.5
EP translation filed:
27.5.2019Grant published:
15.6.2019EPO information:
European Patent Register
Max expiry date:
8.1.2033Expiry date:
8.1.2025
Title:
AGENTS FOR TREATING TRIPLE NEGATIVE BREAST CANCER
Timeline
Today
9.1.2013EP application
27.3.2019EP Publication
27.5.2019Translation submitted
15.6.2019Registration published
8.1.2025Expires
Owner
Name:
ADC Therapeutics SAAddress:
Biopôle Route de la Corniche 3B, 1066, Epalinges, CH
Inventor
Name:
TREMBLAY, Gilles, BernardAddress:
La Prairie, Québec J5R 6N8, CA
Name:
MORAITIS, Anna N.Address:
Laval, Québec H7W 1Z4, CA
Name:
FILION, MarioAddress:
Longueuil, Québec J4J 4M8, CA
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201261584629 PDate:
9.1.2012Country:
US
Classification
Categories:
A61K 39/395, A61K 31/7088, A61P 35/00, A61K 45/06, A61K 47/68, C07K 16/18, C07K 16/30, A61K 39/00
Annual fees
Number
Paid
Expires
Payer
Number: 8
Paid: 6.12.2019
Expires: 8.1.2021
Payer: Árnason Faktor
Number: 9
Paid: 4.12.2020
Expires: 8.1.2022
Payer: Árnason Faktor ehf.
Number: 10
Paid: 3.12.2021
Expires: 8.1.2023
Payer: Árnason Faktor ehf.
Number: 11
Paid: 5.1.2023
Expires: 8.1.2024
Payer: NOVEMBER FIRST A/S
Number: 12
Paid: 20.12.2023
Expires: 8.1.2025
Payer: NOVEMBER FIRST A/S